Recent Updates
Recently added Catalysts
PEN

Penumbra, Inc. to Present at the Goldman Sachs 40th Annual Global Healthcare Conference Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Goldman Sachs 40th Annual Global Healthcare...

Key Takeaway: ALAMEDA, Calif. , May 29, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the Goldman Sachs 40 th Annual Global Healthcare Conference in Rancho Palos Verdes, CA on Tuesday, June 11 , 2019. A webcast of the pres

Full Press Release Details

ALAMEDA, Calif. , May 29, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the Goldman Sachs 40 th Annual Global Healthcare Conference in Rancho Palos Verdes, CA on Tuesday, June 11 , 2019.
Event: Goldman Sachs 40 th Annual Global Healthcare Conference
Date: Tuesday, June 11, 2019
Time: 5:00pm ET / 2:00pm PT
A webcast of the presentation will be available by visiting the investors section of the company's website at www.penumbrainc.com . The webcast will be available on the company's website for at least two weeks following the event.
About Penumbra Penumbra, Inc., headquartered in Alameda, California , is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets innovative products and has a broad portfolio that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the United States , most of Europe , Canada and Australia , and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc. For more information, visit www.penumbrainc.com .
Investor Relations Penumbra, Inc. 510-995-2461 [email protected]
SOURCE Penumbra, Inc.

Related Links

21 %

Last updated: May 29, 2019